Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
Where
Shanghai
Age
18 years to 75 years
People
30
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07003490
Phase 3Taking people
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
450
Run by
Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06954246
No phaseTaking people
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years to 80 years
People
100
Run by
RenJi Hospital
See details and how to joinNCT07026110
No phaseTaking people
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
Where
Beijing
Age
18 years and over
People
40
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07026669
Phase 2Taking people
Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years to 80 years
People
77
Run by
Jian Chen
See details and how to joinNCT06205927
Phase 2Taking people
Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer
Where
Tianjin
Age
18 years and over
People
84
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06775678
No phaseTaking people
Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer
Where
Fuzhou
Age
18 years to 70 years
People
224
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07024433
Early phase 1Enrolling by invitation
⁶⁸Ga-DPA in the Lung Cancer Diagnosis
Where
Beijing
Age
18 years to 85 years
People
40
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07023068
Phase 2Taking people
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years to 80 years
People
43
Run by
Shanghai Proton and Heavy Ion Center
See details and how to joinNCT05613452
Phase 2Taking people
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
Where
Shanghai
Age
75 years and over
People
29
Run by
Jian Chen
See details and how to joinNCT06311981
Phase 2Taking people
Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer
Where
Jinan
Age
18 years and over
People
26
Run by
Pingping Song
See details and how to joinNCT05765877
Phase 3Taking people
A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
Where
Jinan
Age
18 years to 75 years
People
808
Run by
Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06754644
Phase 2Taking people
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）
Where
Guangzhou
Age
18 years to 75 years
People
32
Run by
Sun Yat-sen University
See details and how to joinNCT06924398
Phase 2Taking people
Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC
Where
Xiamen
Age
18 years and over
People
33
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06929936
Phase 2Not yet taking people in China
Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer
Where
Beijing
Age
18 years to 75 years
People
46
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07004712
Phase 1Taking people
A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC
Where
Beijing
Age
18 years and over
People
21
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06969612
Phase 3Taking people
Omitting CTV for Primary Tumor in LS-SCLC
Where
Guangzhou, Hangzhou
Age
18 years to 75 years
People
852
Run by
Sun Yat-sen University
See details and how to joinNCT07008716
No phaseNot yet taking people in China
AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center Study
Where
Nanjing
Age
18 years to 75 years
People
142
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07005791
No phaseTaking people
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Where
Wuhan
Age
18 years and over
People
55
Run by
Liu Huang
See details and how to joinNCT06413212
Phase 1Taking people
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Where
Wuhan
Age
18 years and over
People
60
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06945523
Phase 2Taking people
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
Where
Wuhan
Age
18 years and over
People
25
Run by
Liu Huang
See details and how to joinNCT06199895
Phase 1/2Taking people
AK129 Combination Therapy for Advanced Solid Tumors
Where
Shenyang
Age
18 years to 75 years
People
230
Run by
Akeso
See details and how to joinNCT06943820
Phase 2Not yet taking people in China
Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC
Where
Beijing
Age
18 years and over
People
80
Run by
Bi Nan
See details and how to joinNCT06998719
No phaseTaking people
Early Intervention Strategies for Lung Cancer
Where
Guangzhou
Age
40 years to 74 years
People
16,000
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06988943
Phase 3Taking people
Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study
Where
Guangzhou
Age
18 years to 75 years
People
360
Run by
Yang Hong
See details and how to joinNCT06598527